From the publishers of JADPRO
Gastrointestinal Stromal Tumor
Resource Center
Menu
Resources
Videos
Videos
Quizzes
News & Literature Highlights
Case Studies
Advertisement
Tools for the Diagnosis and Treatment of GIST
0 seconds of 0 seconds
Volume 90%
Press shift question mark to access a list of keyboard shortcuts
Keyboard Shortcuts
Enabled
Disabled
Play/Pause
SPACE
Increase Volume
↑
Decrease Volume
↓
Seek Forward
→
Seek Backward
←
Captions On/Off
c
Fullscreen/Exit Fullscreen
f
Mute/Unmute
m
Decrease Caption Size
-
Increase Caption Size
+ or =
Seek %
0-9
Live
00:00
00:00
00:00
Tools for the Diagnosis and Treatment of GIST
Last Updated: Thursday, July 25, 2024
Advertisement
News & Literature Highlights
Chinese Journal of Gastrointestinal Surgery
Analysis of the efficacy of adjusting the dose of imatinib with therapeutic drug monitoring in adjuvant treatment after complete resection of gastrointestinal stromal tumors
Cureus
Optimizing outcomes in gastrointestinal stromal tumors: A surgeon's perspective
Future Oncology
The INSIGHT study: A randomized, phase III study of ripretinib versus sunitinib for advanced gastrointestinal stromal tumor with KIT exon 11 + 17/18 mutations
JADPRO
Management of patients with advanced gastrointestinal stromal tumor: Emphasis on fourth-line treatment with ripretinib
Advances in Anatomic Pathology
Gastrointestinal stromal tumors: Variants and some pitfalls that they create
BJC Reports
Different efficacy of tyrosine kinase inhibitors by KIT and PGFRA mutations identified in circulating tumor DNA for the treatment of refractory gastrointestinal stromal tumors
Journal of Cancer Research and Clinical Oncology
Current drug resistance mechanisms and treatment options in gastrointestinal stromal tumors: Summary and update
Journal of Cancer Research and Clinical Oncology
Overall survival of patients with KIT-mutant metastatic GIST in the era of multiple kinase inhibitor availability
Surgical Endoscopy
Population-based long-term prognosis analysis of subcutaneous gastrointestinal stromal tumors
Cureus
Neoadjuvant imatinib in gastrointestinal stromal tumors (GIST): The first analysis of a Mexican population
Advertisement
Case Studies
Biomarker Testing for Genetic Evaluation of GISTs
Treating a Patient Newly Diagnosed With GIST
Advertisement
Quizzes
Test your knowledge of biomarker testing for genetic evaluation of GISTs
Test your knowledge of newly diagnosed GIST